ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardiovascular Epidemiology and Prevention

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1571146

Epidemic of lower extremity peripheral arterial disease in China: Current trends and future prediction

Provisionally accepted
Jianxing  YuJianxing Yu1Yuhan  ZhangYuhan Zhang2Qingqing  ZhangQingqing Zhang3Jinyi  WangJinyi Wang3Aiqin  GuAiqin Gu3*Jing  WeiJing Wei3*Chuanmeng  ZhangChuanmeng Zhang3*
  • 1Linyi University, Linyi, Shandong Province, China
  • 2Southern Medical University, Guangzhou, Guangdong, China
  • 3Jiangsu Taizhou People's Hospital, Taizhou, Jiangsu Province, China

The final, formatted version of the article will be published soon.

Lower extremity peripheral artery disease (PAD) reflects the overall condition of the cardiovascular system. Due to its often asymptomatic nature, PAD is frequently overlooked. We aimed to estimate the disease burden of PAD in China over the past 30 years and to project future trends over the next 25 years. The incidence and disability-adjusted life years (DALYs) of PAD was extracted from the Global Burden of Disease (GBD) database and subsequently described. Joinpoint regression was used to assess trends from 1990 to 2021, and an age-period-cohort model was constructed to examine the influence of period and cohort effects on incidence and DALYs of PAD. A Bayesian APC model was also applied to forecast trends through 2046. In 2021, the annual number of new PAD cases in China was 2.45 (95% UI: 2.11-2.85) million, of which 1.74 (1.50-2.03) million were female and 0.71 (0.61-0.83) million were male. The number of new cases in 2021 was obviously higher than that in 1990 among females and males. The age-standardized incidence rate (ASIR) exhibited an increasing trend among males, while a decreasing trend was observed among females.Incidence number rose across all age groups, but rates declined in females. Period effects were identified as high-risk factors for PAD incidence and in both sexes, whereas the cohort effects appeared protective. The number of new cases is projected to rise from 2.45 million in 2021 to 4.01 million by 2046, while the ASIR remains stable . Trends in DALYs showed similar patterns. The burden of PAD in China has increased markedly from 1990 to 2021 and is expected to continue rising over the next 25 years. Efforts to reduce modifiable risk factors-such as smoking and metabolic diseases-and to enhance PAD prevention and management, including the establishment of Pan-Vascular Management Center, are urgently needed.

Keywords: lower extremity peripheral arterial disease, disease burden, prediction, APC analysis, BAPC analysis

Received: 13 Feb 2025; Accepted: 29 May 2025.

Copyright: © 2025 Yu, Zhang, Zhang, Wang, Gu, Wei and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Aiqin Gu, Jiangsu Taizhou People's Hospital, Taizhou, 225300, Jiangsu Province, China
Jing Wei, Jiangsu Taizhou People's Hospital, Taizhou, 225300, Jiangsu Province, China
Chuanmeng Zhang, Jiangsu Taizhou People's Hospital, Taizhou, 225300, Jiangsu Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.